What turned you on to biology in the first place? Music led me to science. When I started college, I didn't know what I wanted to 'be when I grew up'. Frankly, I wasn't very excited about going to college in general, but I enrolled at the University of Texas (UT Austin) in an honors liberal arts program (called Plan II) that introduced me to an intellectual group of people (mostly in the humanities, but some scientists as well). I discovered rapidly that college was NOT merely a continuation of high school and that I loved the intellectual environment. However, 'liberal arts' wasn't an attractive career aspiration. I've always liked challenges and since everyone else seemed to want to be a physician and it was one of the most competitive majors, I declared as a premed along with the liberal arts major.
However, in my first year at UT, I took a music appreciation course and fell in love with classical music. I attended every concert that I could get into and became enamored with the idea of becoming the conductor of a major symphony orchestra (it remains a fond pipe dream!). I began piano and violin classes, as well as theory courses for the music majors. However, I had never had music lessons as a child and it was too late for me at the age of 19 to develop the 'ear'. Alas! An unfulfilled dream.
Q & A
Nevertheless, it was music that led me to science. I've always had a passable singing voice and since I had never learned any other instrument, developing voice as my 'instrument' was the only logical course of action. However, voice lessons cost money and my widow mother was barely able to afford my tuition/fees/food. There was nothing left over for something as frivolous as voice lessons. So, I needed to get a job to earn money for voice lessons. There was a biology professor whose class I had enjoyed in my freshman year and I went to ask that professor for a job. His name is Michael Menaker (now a professor at the University of Virginia) and he was the first person who had a really profound impact on my decision to become a scientist. When I asked him for a job, he looked at me sideways (he knew who I was because I had asked a lot of questions in class) and said, "Yeah . . . I've got a job for you" and he put me to work in the lab. That began a working relationship with Dr. Menaker that would last the remainder of my undergraduate career.
I earned the money to take voice lessons, but more importantly I learned that I liked scientific research. I've always felt that research was like playing a chess game against nature. I resonate with a quote from Sir Peter Medawar that "the art of research is that of making (an apparently intractable) problem soluble by finding out (experimental) ways of getting at it -soft underbellies and the like". Despite gravitating to research, however, I wasn't very successful at it as an undergraduate (or for most of my graduate career). Most people would have reacted to this lack of success by fleeing, but I just dug in stronger. I was ultimately accepted into medical schools and graduate schools, and I think the main reason that I finally decided to go to graduate school was because my undergraduate research project didn't work. If it had worked, I probably would have felt a sense of closure and could have gone on to medical school. But because my project had not worked, I went to graduate school to finish it off.
Who were your mentors? My undergraduate research in Dr. Menaker's laboratory concerned the biological 'clocks' that time us and most other organisms. I became fascinated by these timekeepers, also called circadian (daily) rhythms, and that experience with Menaker inspired me to become a chronobiologist. Consequently, I went to Stanford University as a graduate student to study with the 'head honcho' (at that time) of chronobiology, Dr. Colin Pittendrigh (member of the National Academy). 'Pitt' (as everyone called him) was one of the smartest scientists that I've had the pleasure of knowing; he defined many of the key questions in chronobiology that I (and the rest of the field) are still characterizing.
After graduate school, I went to Harvard University for postdoctoral studies with another major figure in the chronobiology field, Dr. J.W. 'Woody' Hastings (member of the National Academy). Hastings' claim to fame has been the study of bioluminescence in bacteria and algae. In some dinoflagellate algae, bioluminescence exhibits a circadian rhythm and therefore provides a rhythmically glowing 'read-out' of the endogenous biological clock. It has been a great system to study the biochemical control by which the central biological clock controls an observable rhythmic output (in this case, bioluminescence). In our later work on cyanobacteria, we used the same principle and instrumentation for monitoring rhythms, except that we genetically engineered the cyanobacteria to be rhythmically bioluminescent (cyanobacteria are not normally bioluminescent). I had a blast in Hastings' lab. I loved Boston and I loved working on bioluminescent microbial organisms. Hastings and I established an excellent working relationship and friendship that continues to this day. His approach to operating a lab was very laissez faire; he provided an excellent environment without much direction and certainly without looking over the shoulders of his personnel. People in Hastings' lab either flowered or foundered from the absence of direction. I blossomed.
How do you view failures? I have failed more frequently than I have succeeded. My survival as an active scientist is largely due to the persistence mentioned above, and my mantra has been: as long as I keep moving, failures become turning points. In my case, one failure that became a turning point was the aforementioned experience as an undergraduate researcher that led me to graduate school rather than medical school. Another case was during graduate school, when I almost gave up due to lack of progress, but then reoriented my research area with the final result of obtaining my PhD. Finally, my postdoctoral research went well, but as a new Assistant Professor at Vanderbilt University, I again faced a watershed. The dinoflagellate alga that I had researched in Hastings' lab was captivating, but I recognized that its lack of genetics was a major handicap in the age of molecular genetics. I therefore began to develop the genetically tractable alga Chlamydomonas as a model system for circadian studies. While I made progress with Chlamydomonas clocks, undoubtedly the most significant aspect of working on Chlamydomonas circadian rhythms was that it provided a segue to the next phase of my professional career. I met and established a collaboration with Dr. Takao Kondo (Nagoya University, Japan), who also worked on Chlamydomonas chronobiology. We joined forces collaboratively; I worked with him in Japan in 1986 and in 1994 and he spent a sabbatical in my lab in 1990-91. During his sabbatical, we investigated the possibility of other model systems for the study of circadian rhythms and hence began the cyanobacterial project that has principally defined my career. The collaboration with Kondo was a wonderful chapter in my life. I learned to love Japan and its people/culture, and I formed a strong friendship with Kondo. 
Do you feel
under undue pressure to demonstrate the potential relevance of your research for medicine or other 'applications'? I have two reactions to the issue of 'relevance'. On the one hand, it is discouraging that the kind of fascinating basic research that inspired me to go to graduate school instead of medical school has become extraordinarily difficult to fund (there are some exceptional scientists who keep it going, such as my colleague at Vanderbilt, Dr. Ken Catania). On the other hand, taxpayers deserve to know what they're paying for, and understandably they tend to think that much basic research is a waste of their money. One reflection of this is the relative funding of the NSF vs. the NIH in the USA. My field -chronobiology -has ramified from basic biological interest to many areas of medicine and health, and this transformation has undoubtedly helped it to survive and prosper. For me personally, I am diversifying our unabashedly basic research program towards including more applied studies (in humans and mice); at this stage of my career, I'd like at least some of my work to be directly pertinent to the health and well-being of people.
More broadly, however, we need to get the message to the ordinary taxpayer and to legislators of the importance of basic research and of stable, longterm funding for research that only governments can afford to support. I wonder if we could convince Fox News in the USA to have a 'redneck scientist' segment in which a 'salt of the earth' scientist explains to the Fox audience how basic research helps them individually.
You mentioned that music led you to science. Do you see any parallels between these two spheres? Music continues to be important to me. I sing with the Nashville Symphony Chorus, and the rehearsals and performances of the classical choral repertoire are a regular series of oases in my life. On the one hand, I am just 1 out of 145 voices and am never recognized individually. On the other hand, it is a privilege and pleasure for me to have the opportunity to be a part of a program with professional musicians (they are totally out of my league). My choral participation is a metaphor for the way I view my ultimate contribution to science. There are few scientists who achieve name recognition status, and almost all of those who do reach that stature during their research-active years are practically forgotten within a few years after their retirement. For example, I have been shocked that the work and contributions of my graduate supervisor (Pittendrigh) -a dominant figure of chronobiology who died 17 years ago -are rarely discussed nowadays. Therefore, lasting personal recognition is not a realistic motivation for becoming a researcher/teacher. However, we contribute to a process that is larger than ourselves. In that sense, we are each a 'voice in the chorus'. While I was initially attracted to science by the fallacy that I might be recognized as having accomplished great things, now my goals are more realistic: firstly, in my teaching, I can influence the lives and decisions of hundreds of students every year in ways that will be largely unknowable to me and, secondly, in my research, I can enjoy an endeavor that remains fresh and challenging as new experimental results force us to continuously reevaluate previous conclusions.
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Precision genome engineering Dana Carroll
What is precision genome engineering? Exactly that! You know what a genome is; 'engineering' means that we want to change that DNA, and 'precision' means we want to do it in a very specific, targeted way.
Sounds challenging, why would you want to do that? Lots of reasons. For example, we might want to make a mutation in a gene in an experimental organism in order to see what the effect was and thus get an insight into the gene's function. With real precision, we could introduce an exact mutation that corresponds to a human genetic disease allele into an experimental organism. That would allow us to examine the physiological consequences of that mutation in more detail than we could just by looking at people.
Are there some more practical, real-world applications? You bet! People are using precision genome engineering with crop plants and food animals to give them improved characteristics. Think about maize that was more drought resistant, or canola that produced more beneficial oil. How about pigs with more muscle mass -call that pork -or dairy cows with no horns to bother their sisters or the farmer. These modifications are already under way.
How can you get these changes to be made efficiently and with real specificity? The key is to use proteins that will cut DNA -called nucleases -and to direct them to exactly the place in the genome that you want to modify. The first engineered proteins of this kind were called zinc-finger nucleases, or ZFNs. They have a nuclease attached to zinc finger modules that come from natural DNA binding proteins (mainly transcription factors) and know how to find and bind to very specific DNA sequences. There are natural and synthetic fingers that in the right
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combination can recognize quite a range of DNA sequences. About four years ago, another type of DNAbinding module was characterized that has a very simple way of recognizing DNA -one module for each base pair. The nucleases made from these are called TALENs (transcription activator-like effector nucleases), and they have stolen quite a bit of territory from ZFNs. So these proteins make a cut in the DNA strand, but what happens then? Once a break is made at a specific site by the nuclease, the cell's double strand repair machinery hurries to fix it and sometimes makes a mistake. This introduces a mutation right at the break site, and often knocks out the function of a gene. Another type of repair uses a DNA template to copy information across the break. If we put into cells a template that carries sequence changes we want to introduce, they will often get copied in. That's how you would put in a human disease mutation, for example. Together ZFNs and TALENs have been used successfully to modify the genomes of about 30 different species, including humans.
Humans? You're messing with my genome? No (not yet, but stay vigilant). Lots of genome engineering has been done in cultured human cells, partly to make disease models, partly just to work out the technology. Ultimately we want to use these nucleases for beneficial gene therapy. Right now there are clinical trials going on with ZFNs targeted to the human CCR5 gene. The product of this gene is a protein that the human immunodeficiency virus (HIV) needs in order to infect T cells. It turns out we can get along without this protein -there are natural CCR5 mutants. The therapy is to take T cells from HIV-infected people, treat them in the lab to knock out CCR5, then put them back into the same person. This will prevent the development of AIDS by providing a population of HIV-resistant T cells, and there won't be a rejection problem because the cells came from the same person who receives them.
Sounds amazing, but what can you do besides help AIDS patients?
The things that look easiest right now are ones where the nuclease treatment
